Speaker: John Cabeca, Director of the Silicon Valley United States Patent and Trademark Office More details to come. Date/Time: April 18 at 6:00 pm Place: AMN Healthcare Auditorium, 12400 High Bluff Drive, San Diego, CA 92130 Buffet will be served. Members and Students: $20 Non-Members: $30
Intellectual Property Problems and Solutions for Biotechnology, Medical Device, and Pharmaceutical Companies Panelists: Randy Berholtz - Executive Vice President, Corporate Development and General Counsel at Innovus Pharmaceuticals, Inc. Paul Lee - Senior Lead Intellectual Property Counsel at Dexcom Alan Chang - Senior Intellectual Property Counsel at Dexcom Roberta German - Biotech Patent Agent at Sorrento [...]
IPWatchdog – a patents and patent law blog – IPwatchdog.com On February 27, 2019, Robert Schaffer, Joseph Robinson, and Dustin Weeks discussed the Federal Circuit opinion, CenTRAK, Inc. v. Sonitor Technologies, Inc., No. 2017-2510, slip opinion (Fed. Cir., Feb. 14, 2019) (PDF link here). The opinion stated that the written description requirement is satisfied if [...]
This column highlights some of the more notable recent online notices, newsletters, and blogs dealing with IP prosecution issues. IPWatchdog – a patents and patent law blog – IPwatchdog.com On February 22, 2019, IPWatchdog remarked that bipartisan meetings in Congress are searching for legislative solutions to the Section 101 patent eligibility problems involving biotechnology, medical [...]
Startup IP: The Investors’ Perspective SDIPLA presents a panel discussion on the value investors place on Startup IP, including what investors look for in Startup IP, how investors’ expectations evolve as a company grows, and how investors weigh Startup IP with other valuation factors. Panelists: Joel Martin - Dauntless Pharmaceuticals, Marco Thompson - EvoNexus, and Desmond [...]
